Turnkey medical cannabis project in Portugal with pre-licenses, EU grant approved, and ready for growth for €550k OBO

2,000m² approved construction plan for a state-of-the-art facility on a ~10,000 m² wholly owned plot in Portugal

Designed for the pharma-grade extraction market, targeting medical cannabis products such as oral solutions, full-spectrum extracts, oils, and isolates

Projected output of ~9 tons of raw material annually on a single shift, with the potential to double production with 3 shifts

Defined product lines and secured LOI's for potential offtake to ensure strong demand and market penetration upon launch

All necessary production equipment has been pre-negotiated

~€750k invested to date on the project (i.e. architectural, topographic, and engineering)

~€3.5–4 million EU grant with high probability to be approved as have been awarded before

Spanish and German subsidiaries included (Note: no active revenues or operations)

Layout, architectural design, and basic engineering finalized. A geotechnical survey and detailed engineering are required to complete construction. EPC contract finalised awaiting NTP/contract signing including key CO2 extraction technology package from first class company.

An adjoining ~8,000 m² plot has been reserved by the local municipality for potential expansion of the business

Company has accumulated approximately €560,000 in tax losses carried forward, which the acquirer can leverage for tax optimization

This project offers a rare opportunity to enter the European medical cannabis market with a turnkey project. With substantial groundwork completed, regulatory compliance secured, and a strategic location in Portugal, the foundation for scalable growth is in place